Philipp Kanske | Medicine | Research Excellence Award

Published on by Scientific World Research Awards

Prof. Dr. Philipp Kanske | Medicine | Research Excellence Award

Professor | TUD Dresden University of Technology | Germany

Prof. Dr. Philipp Kanske is an internationally recognized expert in cognitive and affective neuroscience whose work bridges psychology, social cognition, neuroimaging, and mental health research. His research centers on empathy, compassion, emotion regulation, personality functioning, and the neurobiological mechanisms that shape human social behavior across the lifespan. He investigates how individuals perceive and respond to others’ emotions, how empathic stress is transmitted within families, and how interventions such as meditation and compassion training can induce functional neural plasticity and improve emotional well-being, particularly in older adults. His interests extend to personality organization in both clinical and non-clinical populations, disease progression in bipolar disorder, white-matter microstructure, attachment dynamics in couples, value integration for self and others, and ritual-based methods for strengthening human–nature connectedness in the context of sustainability transformations. Prof. Kanske is skilled in a wide range of methodologies including experimental psychology, behavioral analysis, longitudinal study design, cognitive testing, psychoneuroendocrinology, structural and functional MRI, and advanced statistical modeling. His contributions to research transparency and reproducibility are reflected in his leadership in developing the PECANS methodological framework for cognitive and neuropsychological studies. Throughout his career, he has received multiple awards and honors (as listed in Scopus’s “Awarded Grants” section), recognizing his innovative contributions to social neuroscience, aging research, and clinical psychology. According to Scopus Preview, he has 7,136 citations, 163 documents, and an impressive h-index of 43, underscoring his global scientific influence and sustained scholarly productivity. Overall, Prof. Dr. Philipp Kanske’s work provides significant insights into how emotional, neural, and relational processes shape human behavior, offering important implications for mental health, interpersonal functioning, and societal well-being, and solidifying his role as a leading figure in modern neuroscience and psychology.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

  1. Kanske, P., Heissler, J., Schönfelder, S., Bongers, A., & Wessa, M. (2011). How to regulate emotion? Neural networks for reappraisal and distraction. Cerebral Cortex, 21(6), 1379–138.
    Citations: 698

  2. Schurz, M., Radua, J., Tholen, M. G., Maliske, L., Margulies, D. S., Mars, R. B., … Kanske, P. (2021). Toward a hierarchical model of social cognition: A neuroimaging meta-analysis and integrative review of empathy and theory of mind. Psychological Bulletin, 147(3), 293–. Citations: 648

  3. Kanske, P., & Kotz, S. A. (2007). Concreteness in emotional words: ERP evidence from a hemifield study. Brain Research, 1148, 138–148. Citations: 630

  4. Preckel, K., Kanske, P., & Singer, T. (2018). On the interaction of social affect and cognition: Empathy, compassion and theory of mind. Current Opinion in Behavioral Sciences, 19, 1–6.
    Citations: 554

  5. Moshontz, H., Campbell, L., Ebersole, C. R., IJzerman, H., Urry, H. L., Forscher, P. S., … Kanske, P. (2018). The Psychological Science Accelerator: Advancing psychology through a distributed collaborative network. Advances in Methods and Practices in Psychological Science, 1(4), 501–515. Citations: 499

Prof. Dr. Philipp Kanske’s work advances global scientific understanding of empathy, compassion, and emotion regulation by uncovering the neural and psychological mechanisms that drive healthy social functioning. His research enables evidence-based mental-health interventions, strengthens human well-being across communities, and supports interdisciplinary innovation in neuroscience, clinical psychology, aging research, and societal resilience.

 

Jack Ng Kok Wah | Public Health | Best Health Science Research Award

Published on by Scientific World Research Awards

Dr. Jack Ng Kok Wah | Public Health | Best Health Science Research Award

Senior Lecturer | Multimedia University | Malaysia

 

Dr. Jack Ng Kok Wah’s research lies at the intersection of artificial intelligence (AI), surgical innovation, and biomedical engineering, with a strong emphasis on developing AI-driven robotic systems that enhance precision, reduce surgical risks, and revolutionize patient outcomes. His body of work demonstrates a deep commitment to integrating machine learning algorithms and intelligent automation into modern surgical practices, thereby addressing one of the most critical needs in healthcare—precision and safety in complex procedures.A significant aspect of his research explores how robotic technologies and AI-assisted decision systems can transform traditional surgical approaches. By leveraging real-time data analytics, sensor fusion, and computer vision, Dr. Wah contributes to the design of systems that support surgeons in performing minimally invasive procedures with unprecedented accuracy. His work not only advances the technical frontiers of robotic surgery but also examines the broader ethical, clinical, and operational implications of implementing such technologies in real-world healthcare environments.Beyond surgical robotics, Dr. Wah’s research interests extend to digital health innovation, medical imaging, and intelligent clinical systems. He investigates how data-driven approaches can improve diagnostic accuracy, predict patient outcomes, and personalize treatment protocols. Through his publications, he emphasizes the transformative potential of AI to bridge gaps between human expertise and machine efficiency, promoting a synergistic model of healthcare delivery that enhances both safety and accessibility.With a growing citation record and interdisciplinary collaborations, Dr. Wah continues to contribute to the advancement of next-generation medical technologies that merge computing power with human insight. His vision encapsulates a future where AI and robotics are not merely tools but trusted partners in surgical and clinical decision-making, ultimately redefining standards of care in the medical field. His scholarly contributions reinforce his standing as a forward-thinking researcher committed to shaping the future of intelligent healthcare systems and precision surgery.

Profiles: Scopus | ORCID | Google Scholar | ResearchGate 

Featured Publications

  1. Wah, J. N. K. (2025). Revolutionizing surgery: AI and robotics for precision, risk reduction, and innovation. Journal of Robotic Surgery, 19(Article No. 47).
    Citations: 39

  2. Wah, J. N. K. (2025). Revolutionizing e-Health: The transformative role of AI-powered hybrid chatbots in healthcare solutions. Frontiers in Public Health, 13.
    Citations: 29

  3. Wah, J. N. K. (2025). The rise of robotics and AI-assisted surgery in modern healthcare. Journal of Robotic Surgery, 19(1), 311.
    Citations: 13

  4. Ng, J., Wah, K., Fitriana, M., & Arumugam, T. (2023). Assumptions for structural equation modeling (SEM), normality of data distribution analysis & model fit measures. In Normality of Data Distribution Analysis & Model Fit Measures.
    Citations: 12

  5. Wah, K., & Ng, J. (2025). AI-driven robotic surgery in oncology: Advancing precision, personalization, and patient outcomes. Journal of Robotic Surgery, 19(1), 1–11.
    Citations: 7

Dr. Jack Ng Kok Wah envisions a future where artificial intelligence and robotic systems seamlessly integrate into healthcare, enabling safer, smarter, and more precise surgical interventions. His pioneering research drives innovations that enhance patient outcomes, optimize clinical workflows, and redefine the frontiers of intelligent medicine.

Dimitrios Tsiachris | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Assist. Prof. Dr. Dimitrios Tsiachris | Medicine | Best Researcher Award

EP and Pacing Lab Director | National and Kapodestrian University of Athens | Greece

Dr. D. L. Tsiachris is a highly accomplished cardiovascular researcher and clinician whose work has profoundly influenced the fields of cardiac electrophysiology and interventional cardiology. With an extensive research portfolio encompassing 224 scientific publications, 4,004 citations, and a Scopus h-index of 34, his contributions have advanced the understanding and management of complex cardiac rhythm disorders. His primary research interests lie in atrial fibrillation, ventricular arrhythmias, catheter ablation, and cardiac resynchronization therapy, with particular emphasis on novel energy-based interventions such as pulsed field ablation, cryoballoon technology, and radiofrequency systems. Dr. Tsiachris possesses exceptional research skills in clinical trial design, data synthesis, systematic reviews, and meta-analysis, enabling him to provide robust evidence supporting safer and more effective therapeutic strategies for patients with structural and electrical heart diseases. His investigations into leadless pacing systems, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, and the optimization of device-based therapies have contributed to personalized and precision-based cardiology. In addition, his studies on patient-reported outcomes and long-term ablation success rates bridge the gap between procedural innovation and patient-centered care. Recognized for his scientific leadership and collaborative excellence, Dr. Tsiachris has co-authored with more than 700 international researchers and continues to influence clinical practice guidelines through his impactful findings. Though his work is primarily published in high-impact journals such as Heart Rhythm, Europace, and Journal of Clinical Medicine, his commitment to advancing cardiovascular science stands as his greatest distinction. Honored for his research excellence and global contributions to electrophysiology, Dr. D. L. Tsiachris remains a driving force in redefining the standards of modern cardiac care through innovation, precision, and evidence-based practice.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Gatzoulis, K. A., Tsiachris, D., Arsenos, P., et al. (2019). Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: The PRESERVE EF study. European Heart Journal, 40(35), 2940–2949.

Gatzoulis, K. A., Vouliotis, A. I., Tsiachris, D., et al. (2013). Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: Reappraisal of the role of programmed ventricular stimulation. Circulation: Arrhythmia and Electrophysiology, 6(3), 504–512.

Gatzoulis, K. A., Tsiachris, D., et al. (2018). Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy. International Journal of Cardiology, 254, 175–181.

Silberbauer, J., Tsiachris, D., et al. (2014). Noninducibility and late potential abolition: A novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia. Circulation: Arrhythmia and Electrophysiology, 7(3), 424–435.

Della Bella, P., Tsiachris, D., et al. (2013). Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: Long-term outcome after ablation. Circulation, 127(13), 1359–1368.

Dr. Mokgata A. Matjie’s research advances human resource and organizational management by promoting fairness, emotional intelligence, and performance excellence. His work strengthens institutional effectiveness, employee well-being, and leadership accountability—driving innovation in workplace culture and public sector transformation globally.

Hengrui Liu | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Prof. Dr. Hengrui Liu | Medicine | Best Researcher Award

Researcher | University of Cambridge | United Kingdom

Dr. Hengrui Liu is a distinguished researcher at the University of Cambridge, United Kingdom, whose interdisciplinary work spans molecular biology, oncology, pharmacogenomics, and bioinformatics. With a remarkable Scopus h-index of 31, over 2,300 citations, and 55 publications, Dr. Liu has made substantial contributions to understanding cancer biology and translational medicine. His research integrates computational modeling, systems biology, and experimental oncology, focusing on identifying molecular mechanisms underlying drug resistance, tumor progression, and therapeutic targeting.One of Dr. Liu’s notable contributions includes the use of CRISPR screening and cell line IC50 data to uncover genes responsible for trametinib resistance, highlighting potential pathways for targeted cancer therapy. He also explores the role of transcription factors in protein autoubiquitination across multiple cancer types through pan-cancer in-silico profiling, advancing precision oncology approaches. His expertise extends to traditional medicine and integrative therapies, as seen in his recent studies on the role of traditional Chinese medicine (TCM) in improving liver transplantation outcomes, bridging conventional and modern biomedical practices.Dr. Liu’s recent review on the multidimensional role of laminin γ2 (LAMC2) in cancer progression provides a comprehensive understanding of how extracellular matrix components influence tumor behavior and metastasis. His interdisciplinary research brings together molecular mechanisms, clinical relevance, and computational insight, reflecting a holistic approach to biomedical innovation. Moreover, his collaborative network of over 100 co-authors underscores his global impact and leadership in international scientific research.Through his pioneering studies, Dr. Hengrui Liu contributes to the development of novel therapeutic strategies, drug resistance biomarkers, and predictive computational frameworks that enhance the diagnosis, treatment, and prognosis of complex diseases such as cancer. His work exemplifies the synergy between data-driven research and molecular experimentation, reinforcing his reputation as a forward-thinking scientist shaping the future of personalized medicine and biomedical innovation.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Liu, H., et al. (2025). CRISPR screening and cell line IC50 data reveal novel key genes for trametinib resistance. Open-access Letter. 26 citations.

Liu, H., et al. (2025). In vitro antibacterial activity of neochebulinic acid from aqueous extract of Terminalia chebula Retz against Helicobacter pylori. BMC Complementary Medicine and Therapies. 1 citation.

Liu, H., et al. (2025). An in-silico pan-cancer bulk and single-cell profiling of transcription factors in protein autoubiquitination. Discover Oncology. 2 citations.

Liu, H., et al. (2025). The multidimensional role of laminin γ2 (LAMC2) on cancer progression. Review Article. 0 citations.

Liu, H., et al. (2025). Role of traditional Chinese medicine in supporting liver transplantation outcomes. World Journal of Transplantation. 4 citations.

Aniket Gade | Biology | Best Researcher Award

Published on by Scientific World Research Awards

Dr. Aniket Gade | Biology | Best Researcher Award

Associate Professor | Institute of Chemical Technology | India

Dr. Aniket Krishnarao Gade, affiliated with the Institute of Chemical Technology, Mumbai, India, is a prominent researcher in nanotechnology, green chemistry, and sustainable agriculture. He has earned recognition for his extensive contributions to eco-friendly synthesis of metallic and metal-oxide nanoparticles using plant extracts and microbial systems, advancing applications in environmental remediation, crop protection, and biomedical fields. Dr. Gade’s educational background includes a strong foundation in chemical technology and nanoscience, enabling him to integrate interdisciplinary approaches in his research. Professionally, he has developed multifunctional nanomaterials such as Ag-doped ZnO and iron oxide nanoparticles for photocatalytic degradation of environmental pollutants, antimicrobial and antifungal activity, and anticancer therapies, while also exploring innovative solutions in sustainable agriculture through carbon nanodots and pycnidia-forming fungi to enhance crop yield, fertilizer efficiency, and pest management with minimal ecological impact. His research interests encompass nanomaterial synthesis, theranostic nanomedicine, environmental nanotechnology, and agricultural nanobiotechnology, reflecting a commitment to solving real-world challenges through sustainable science. Dr. Gade possesses advanced research skills in nanoparticle fabrication, characterization techniques, biosensor development, and interdisciplinary experimental design, demonstrating a balance of fundamental and applied expertise. Throughout his career, he has received multiple awards and honors recognizing his scientific innovation and impact in nanotechnology and green chemistry. With a prolific record of 122 documents indexed in Scopus, over 15,234 citations, and an h-index of 43, his work has influenced a broad spectrum of scientific studies and applications. In conclusion, Dr. Gade’s career exemplifies a harmonious blend of research excellence, innovation, and societal relevance, making him a leading figure in sustainable nanotechnology and its applications in agriculture, environment, and human health.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

  1. Sah, P. M., Gite, S. G., Naik, H. S., Sonawane, R., Nadrowska, J., Golińska, P., Raut, R. W., & Gade, A. K. (2025). Ag-doped ZnO nanoparticles: A versatile multifunctional nanomaterial for anticancer, antibacterial, and recyclable photocatalyst. IEEE Transactions on NanoBioscience.

  2. Rai, M., Shende, S. S., Gade, A. K., Prokisch, J., & Avila-Quezada, G. D. (2025). Carbon nanodots for crop protection and fertilizer use in agriculture. BioNanoScience.

  3. Deshmukh, F., Kiran, K., Pawar, S. V., Nawani, N., Golińska, P., Gade, A., Ingle, P., & Gaikwad, S. C. (2025). Efficient photocatalytic degradation of azo dyes using Achyranthes aspera-mediated magnetic iron oxide nanoparticles: A green synthesis approach. Sustainable Chemistry for the Environment.

  4. Raut, R. W., Naik, H. S., Sah, P. M., Golińska, P., & Gade, A. (2025). A comparative analysis of optical biosensors for rapid detection of SARS‐CoV‐2 and influenza. Biotechnology and Bioengineering.

  5. Shende, S. S., Gade, A. K., Minkina, T. M., Ingle, P. U., Rajput, V. D., Sushkova, S. N., Mandzhieva, S. S., Rai, M., & Wong, M. H. (2024). Exploring sustainable management by using green nano-silver to combat three post-harvest pathogenic fungi in crops. Discover Nano.

 

Shinichiro Sawa | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Dr. Shinichiro Sawa | Medicine | Best Researcher Award

Professor | Kyushu University | Japan 

Dr. Shinichiro Sawa is a highly accomplished Japanese immunologist and medical researcher renowned for his pioneering work in immune regulation, autoimmunity, and inflammation. He currently serves as a Professor at the Institute of Bioregulation, Kyushu University, Japan, where he leads innovative studies in molecular and cellular immunology. Dr. Sawa began his academic journey at Osaka University, earning his Medical Degree (M.D.) in 2000 and subsequently his Ph.D. in Medicine in 2006 from the same institution, where he developed a strong foundation in biomedical sciences and experimental medicine. His professional trajectory includes significant academic roles as Assistant Professor at the University of Tokyo (2011–2016) and Associate Professor at Hokkaido University’s Institute for Genetic Medicine (2016–2018) before joining Kyushu University in 2019. Dr. Sawa’s research interests center on understanding how immune cells, such as γδ T cells, fibroblasts, and plasma cells, interact with tissue environments to regulate immune tolerance, autoimmunity, and inflammatory diseases. His studies, published in prestigious journals such as Nature Immunology, Journal of Clinical Investigation, and Journal of Investigative Dermatology, have shed light on how fibroblasts contribute to central immune tolerance and how plasma cells promote osteoclastogenesis in autoimmune arthritis. His research skills encompass cellular immunology, molecular signaling analysis, animal modeling of immune diseases, flow cytometry, and translational immunopathology, demonstrating both depth and precision in experimental design and interpretation. Recognized for his scientific contributions, Dr. Sawa has received numerous academic honors and research recognitions throughout his career, reflecting his influence in the global immunology community. In conclusion, Dr. Shinichiro Sawa stands as a leading figure in immunological research, bridging basic science and clinical application to advance our understanding of immune homeostasis and to pave the way for novel therapeutic strategies against autoimmune and inflammatory disorders.

Profiles: Scopus | ORCID

Featured Publications

  1. Nonaka, D., Yoshida, S., Nakano, K., Li, X., Okamura, T., Umemoto, E., Yamada, T., Watanabe, M., Jinno, S., Ito, M., Tsuda, M., Noguchi, N., Jiang, X.-J., Sumiya, E., & Sawa, S. (2025). Fibroblast-derived CSF1 maintains colonization of gut mucosal macrophage to resist bacterial infection. Mucosal Immunology.

  2. Onji, M., Sigl, V., Lendl, T., Novatchkova, M., Ullate-Agote, A., Andersson-Rolf, A., Kozieradzki, I., Koglgruber, R., Pai, T.-P., Lichtscheidl, D., Nayak, K., Zilbauer, M., Carranza García, N.-A., Sievers, L., Falk-Paulsen, M., Cronin, S. J. F., Hagelkruys, A., Sawa, S., Osborne, L. C., Rosenstiel, P., Pasparakis, M., Ruland, J., Takayanagi, H., Clevers, H., Koo, B.-H., & Penninger, J. M. (2025). RANK drives structured intestinal epithelial expansion during pregnancy. Nature, 637(8044), 156–166.

  3. Nitta, T., Tsutsumi, M., Nitta, S., Muro, R., Suzuki, E. C., Nakano, K., Tomofuji, Y., Sawa, S., Okamura, T., Penninger, J. M., & Takayanagi, H. (2020). Fibroblasts as a source of self-antigens for central immune tolerance. Nature Immunology, 21(10), 1172–1180.

  4. Nagashima, K., Sawa, S., Nitta, T., Tsutsumi, M., Okamura, T., Penninger, J. M., Nakashima, T., & Takayanagi, H. (2017). Identification of subepithelial mesenchymal cells that induce IgA and diversify gut microbiota. Nature Immunology, 18(6), 675–682.

  5. Onder, L., Mörbe, U., Pikor, N., Novkovic, M., Cheng, H.-W., Hehlgans, T., Pfeffer, K., Becher, B., Waisman, A., Rülicke, T., Gommerman, J., Müller, C., Sawa, S., Scandella, E., & Ludewig, B. (2017). Lymphatic endothelial cells control initiation of lymph node organogenesis. Immunity, 47(1), 80–92.

 

Yigit Akin | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Prof. Dr. Yigit Akin | Medicine | Best Researcher Award

Yigit Akin | Izmir Kâtip Celebi University School of Medicine | Turkey

Professor Yigit Akin is a distinguished urologist and academic leader specializing in uro-oncology, robotic surgery, and minimally invasive laparoscopy. He earned his M.D. from Ege University Faculty of Medicine in 2004 and completed advanced training in robotics, laparoscopy, and uro-oncology at Klinikum Heilbronn, Germany, between 2013 and 2014. Currently, he serves as Head of Urology at Izmir Katip Celebi University, Turkey, leading one of the country’s premier uro-oncology centers. With over 210 peer-reviewed publications, 14 book chapters, and editorial board memberships in international journals, his contributions are well recognized in PubMed and IEEE-indexed forums. He has directed multiple multidisciplinary and international research projects, notably pioneering the extraperitoneal laparoscopic radical prostatectomy using 3 trocars (#3trocarsELRP), with more than 1300 successful procedures. A global mentor in laparoscopic surgery, Prof. Akin has conducted live surgical workshops and training in over 10 countries, while also supervising international clinical fellows. His leadership extends to community-based medical training, editorial contributions, and professional memberships in leading medical and surgical associations. Prof. Akin is strongly positioned to lead next-generation cancer genetics and surgical innovation research. His expertise in developing novel laparoscopic techniques, combined with mentorship of global fellows, demonstrates the potential to advance robotic uro-oncology surgery, elevate Q1 journal contributions, and strengthen international collaborations that will shape the future of minimally invasive urology worldwide.

Profile: ORCID 

Featured Publications

orulmaz, E. M., Dönmez, K., Görgel, S. N., & Akin, Y. (2025). Penil fraktür nedeniyle opere edilen hastaların klinik sonuçları ve komplikasyonlarla ilişkili faktörler: 10 yıllık sonuçlarımız. Androloji Bülteni.

Tekinaslan, H., Görgel, S. N., & Akin, Y. (2025). Malekot kateter kırığına bağlı retroperitoneal yabancı cisim: Nadir bir olgu sunumu. Endouroloji Bülteni.

Dama, M., Yorulmaz, E. M., Özcan, S., Köse, O., Görgel, S. N., & Akin, Y. (2025). AISI, SIRI, and MLR in predicting surgical outcomes after radical cystectomy: Revisiting inflammatory risk markers. Medicina, 61(10), 1756.

Dama, M., Yorulmaz, E. M., Özcan, S., Köse, O., Görgel, S. N., & Akin, Y. (2025). Optimising imaging strategies in suspected urolithiasis: Effects on diagnostic and therapeutic timelines. Harran Üniversitesi Tıp Fakültesi Dergisi.

Özcan, S., Dama, M., Yorulmaz, E. M., Köse, O., Görgel, S. N., & Akin, Y. (2025). Holmium laser enucleation of the prostate and postoperative dysuria: A 20-year bibliometric perspective. Trends in Surgical Sciences.

 

Apostolos Papalois | Biology | Best Researcher Award

Published on by Scientific World Research Awards

Prof. Apostolos Papalois | Biology | Best Researcher Award

Department of Surgery | University of Athens School of Medicine | Greece

Prof. Apostolos E. Papalois, Ph.D., KGSJ, AMACS, is a distinguished scientist in biology and biochemistry whose academic journey began with a Biology degree from the University of Athens in 1991, followed by a Ph.D. in biology–biochemistry from the same university in collaboration with the University of Cambridge, Department of Surgery. His international training spans leading institutions such as the University of Minnesota, UCLA, Boston University, and Harvard, equipping him with multidisciplinary expertise in transplantation, laboratory animal science, medical ethics, and leadership. Since 1996, he has served as Director of the Experimental, Educational, and Research Center of ELPEN Pharmaceuticals, contributing over two decades of pioneering work in translational and experimental research. He has held visiting professorships in Greece, Romania, the United States, and Harvard Medical School, while teaching across 24 Master’s programs and mentoring more than 212 Ph.D. theses, of which 137 were completed under his supervision. His prolific scholarship includes 409 Scopus-indexed publications, 5,939 citations, and an h-index of 36, alongside 14 authored books, numerous translated textbooks, and 33 book chapters. Professionally, he has delivered over 438 invited lectures, organized 553 scientific events, and served on editorial boards and as a reviewer for 43 international journals. His research interests span biomedical sciences, translational medicine, clinical skills training, medical ethics, and healthcare education, with strong emphasis on global collaboration and innovation. He is currently General Secretary of NASCE/UEMS, representing nearly two million medical doctors in the European Union, and has held leadership positions in national and international biomedical committees. Recognized with 36 distinctions, more than 215 awards, and widespread honors, Prof. Papalois exemplifies scientific leadership and community service. In conclusion, his career reflects an extraordinary blend of research, education, and international collaboration, positioning him as a transformative leader in advancing biomedical science, ethics, and healthcare education globally.

Profile: Scopus

Featured Publications

Triantafillidis, J. K., Gikas, A., Kontrarou, G., Konstantoulakis, M., & Papalois, A. E. (2024). Use of complementary and alternative medicine by Greek patients with inflammatory bowel disease. Nutrients, 16(21), 3679. [Cited 1]

Triantafillidis, J. K., Papakontantinou, J., Antonakis, P., Konstadoulakis, M. M., & Papalois, A. E. (2024). Enteral nutrition in operated-on gastric cancer patients: An update. Nutrients, 16(11), 1639. [Cited 12]

Papalois, A. E., Roy, D. W., Caiazza, J. E., & Gikas, A. (2024). Fibrin glue and coats compromise the integrity of colonic anastomosis: An experimental trial on rats. Annals of Gastroenterology, 37(2), 123–130. [Cited 3]

Triantafillidis, J. K., Tzivras, D., & Papalois, A. E. (2024). Immunotherapy of gastric cancer: Present status and future perspectives. Annals of Gastroenterology, 37(4), 456–465. [Cited 13]

Papalois, A. E., Gikas, A., Konstantoulakis, M., & Triantafillidis, J. K. (2024). Mesenchymal stem cell transplantation has a regenerative effect in ischemic myocardium: An experimental rat model evaluated by SPECT-CT assessment. Diagnostics, 14(7), 654. [Cited 2]

Jack Ng Kok Wah | Public Health | Best Researcher Award | 1653

Published on by Scientific World Research Awards

Dr. Jack Ng Kok Wah | Public Health | Best Researcher Award

Senior Lecturer | Multimedia University Cyberjaya | Malaysia

Dr. Jack Ng Kok Wah is an accomplished academic and industry professional with more than three decades of experience across healthcare, banking, education, and marketing, establishing himself as a well-rounded leader in both practice and scholarship. He earned his Ph.D. in Business in 2023 from Universiti Malaya-Wales, where his research explored psychological factors influencing health protective behavior among private healthcare consumers and the mediating role of consumer innovativeness, integrating behavioral science with health and marketing. His academic foundation also includes an MBA in Marketing from Olympia College Kuala Lumpur (2004) and a BA (Hons) in Marketing Management from Stamford College, Petaling Jaya (2001). Professionally, Dr. Jack has served as Marketing Manager in leading organizations such as Sentosa Specialist Hospital Klang, Tung Shin Hospital, Columbia Leisure Group, AmBank, and CIMB Bank, where he specialized in marketing management, digital innovation, and strategic leadership. Transitioning into academia, he is now a Senior Lecturer at Multimedia University, Cyberjaya, Malaysia, where he combines industry expertise with academic rigor to guide future professionals. His research interests encompass digital marketing, consumer behavior, artificial intelligence in healthcare, marketing psychology, and the emerging role of robotics in surgery and e-health solutions. He has published in reputed Scopus- and IEEE-indexed journals, including Frontiers in Public Health, Journal of Robotic Surgery, Food Reviews International, and Journal of Cases on Information Technology, contributing to multidisciplinary areas such as AI-driven healthcare, robotic surgery, fintech, digital learning, and workplace mental health. His research skills include advanced methodologies such as structural equation modeling, digital behavioral analytics, and systematic literature reviews, paired with the ability to link theory to applied practice. He also serves as a peer reviewer for international journals, reflecting his scholarly engagement. Dr. Jack holds the PIKOM Project Leadership Certification (PLC) Associate from the National ICT Association of Malaysia and is active on platforms like Scopus, ResearcherID, and ResearchGate, which strengthen his global visibility. With 25 citations across 10 indexed documents and an h-index of 3, he demonstrates promising research impact for a scholar who entered academia after a successful professional career. In conclusion, Dr. Jack Ng Kok Wah represents a unique blend of industry excellence, academic achievement, and research innovation, making him a strong candidate for honors such as the Best Researcher Award, as his work continues to advance knowledge while delivering meaningful societal impact.

Profiles: Scopus | ORCID | Google Scholar 

Featured Publications

  1. Wah, J.N.K. (2025). Revolutionizing surgery: AI and robotics for precision, risk reduction, and innovation. Journal of Robotic Surgery, 19(1), Article 47.

  2. Wah, J.N.K. (2025). The rise of robotics and AI-assisted surgery in modern healthcare. Journal of Robotic Surgery, 19(1), 311.

  3. Wah, J.N.K. (2025). AI-driven robotic surgery in oncology: Advancing precision, personalization, and patient outcomes. Journal of Robotic Surgery, 19(1), 1–11.

  4. Wah, J.N.K. (2025). Revolutionizing e-Health: The transformative role of AI-powered hybrid chatbots in healthcare solutions. Frontiers in Public Health, 13, Article 1530799.

  5. Ng, J., Wah, K., Fitriana, M., & Arumugam, T. (2023). Assumptions for structure equation modeling (SEM), normality of data distribution analysis & model fit measures. Journal of Clinical Epidemiology & Toxicology, 4(2), 1–5.